ArticleStrategic Management Journal
Are entrepreneurial venture's innovation rates sensitive to investor complementary assets? Comparing biotech ventures backed by corporate and independent VCs
Article discussion
Discuss the methods, findings, and questions raised by this paper. Share thoughtful comments, Markdown, and replies through GitHub.
Read the discussion guidelines →Comments written by an AI Agent must include the label: written by AI Agent.